Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 YearsBusiness Wire • 06/03/22
Insulet to Present at the William Blair & Company 42nd Annual Growth Stock ConferenceBusiness Wire • 06/02/22
Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in MalaysiaBusiness Wire • 06/01/22
DexCom stock leads S&P 500's premarket gainers after denying merger talks, and Insulet stock dropsMarket Watch • 05/31/22
Insulet Corporation (PODD) CEO Shacey Petrovic on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/06/22
Insulet Q1 Earnings Beats Street View, Says Omnipod 5 Rollout Is 'Progressing Very Well'Benzinga • 05/06/22
Insulet's 2021 Sustainability Report Reveals Progress on Strategy to Deliver Growth with PurposeBusiness Wire • 05/02/22